US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aldeyra Therapeutics

4.81

-0.1800-3.61%

Post-market: 4.910.1000+2.08%17:19 EDT

Volume:1.51M

Turnover:7.13M

Market Cap:288.10M

PE:-4.97

High:4.92

Open:4.90

Low:4.23

Close:4.99

Loading ...

Overview Company News Filings

Aldeyra Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview

Aldeyra Therapeutics Secures Orphan Designation from European Medicines Agency for ADX-2191 to Treat Retinitis Pigmentosa

Aldeyra Therapeutics Inc - Phase 2/3 Trial of Adx-2191 Expected in 2025

THOMSON REUTERS

Aldeyra Therapeutics Receives Orphan Designation From the European Medicines Agency for Adx-2191 for the Treatment of Inherited Retinal Dystrophies Including Retinitis Pigmentosa

THOMSON REUTERS

Aldeyra Therapeutics Announces FDA Acceptance of Reproxalap NDA for Dry Eye Disease with PDUFA Target Date Set for December 2025

Aldeyra Therapeutics Leads The Pack Among 3 Promising Penny Stocks

Simply Wall St.

Aldeyra Therapeutics: Positioned for Success with ADX-2191 and Strategic Portfolio Expansion

Aldeyra Therapeutics (ALDX) Gets a Buy from JonesTrading

BRIEF-Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter From The U.S. Food And Drug Administration For Adx-2191

Aldeyra Therapeutics: Buy Rating Affirmed Amidst Promising Developments in Dry Eye Disease Treatment and Strategic Partnerships

Aldeyra Therapeutics Resubmits New Drug Application for Reproxalap to FDA for Dry Eye Disease Treatment

Aldeyra Therapeutics Inc. Concluded Annual Stockholders Meeting

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025

CORRECTED-US FDA approves Alcon's new dry-eye drug (May 28)

Aldeyra Therapeutics: Strong Financial Position and Positive Trial Outcomes Drive Buy Rating

Aldeyra Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Aldeyra Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Strategic Partnerships

BRIEF-Aldeyra Therapeutics Inc Says New Drug Application Resubmission Is Anticipated Mid‑2025

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALDX\",,,,,undefined,":{"symbol":"ALDX","market":"US","secType":"STK","nameCN":"Aldeyra Therapeutics","latestPrice":4.81,"timestamp":1754078400000,"preClose":4.99,"halted":0,"volume":1510976,"hourTrading":{"tag":"盘后","latestPrice":4.91,"preClose":4.81,"latestTime":"17:19 EDT","volume":6010,"amount":28938.2,"timestamp":1754083146618},"delay":0,"floatShares":47668035,"shares":59895588,"eps":-0.968052,"marketStatus":"Market Closed","change":-0.18,"latestTime":"08-01 16:00:00 EDT","open":4.9,"high":4.92,"low":4.23,"amount":7127038.079744,"amplitude":0.138277,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.968052,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1399003200000,"exchange":"NASDAQ","adjPreClose":4.99,"preHourTrading":{"tag":"盘前","latestPrice":4.89,"preClose":4.99,"latestTime":"09:27 EDT","volume":4859,"amount":23562.107312,"timestamp":1754054870021},"postHourTrading":{"tag":"盘后","latestPrice":4.91,"preClose":4.81,"latestTime":"17:19 EDT","volume":6010,"amount":28938.2,"timestamp":1754083146618},"volumeRatio":1.3428965301384317,"impliedVol":0.2219,"impliedVolPercentile":0.02},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALDX\",,,,,undefined,":{"symbol":"ALDX","floatShares":47668035,"roa":"-32.60%","roe":"-65.19%","lyrEps":-0.938919,"volumeRatio":1.3428965301384317,"shares":59895588,"dividePrice":0,"high":4.92,"amplitude":0.138277,"preClose":4.99,"low":4.23,"week52Low":1.14,"pbRate":"4.53","week52High":7.2,"institutionHeld":0,"latestPrice":4.81,"eps":-0.968052,"divideRate":0,"volume":1510976,"delay":0,"ttmEps":-0.968052,"open":4.9,"prevYearClose":4.99,"prevWeekClose":5.17,"prevMonthClose":4.99,"prevQuarterClose":3.83,"fiveDayClose":5.17,"twentyDayClose":4.3,"sixtyDayClose":2.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555559704","title":"Aldeyra Therapeutics Inc  expected to post a loss of 24 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2555559704","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555559704?lang=en_us&edition=fundamental","pubTime":"2025-07-29 05:26","pubTimestamp":1753737978,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Inc  expected to post a loss of24cents a share - Earnings Preview Aldeyra Therapeutics Inc ALDX.OQ ALDX.O is expected to  show no change in quarterly revenue when it reports  resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nL8N3TP28I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX"],"gpt_icon":0},{"id":"2553039202","title":"Aldeyra Therapeutics Secures Orphan Designation from European Medicines Agency for ADX-2191 to Treat Retinitis Pigmentosa","url":"https://stock-news.laohu8.com/highlight/detail?id=2553039202","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553039202?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:00","pubTimestamp":1753354844,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Inc. has announced that the European Medicines Agency  has granted Orphan Designation for ADX-2191, their methotrexate intravitreal injection, for the treatment of inherited retinal dystrophies including retinitis pigmentosa. This regulatory milestone underscores the crucial need for effective treatments for retinitis pigmentosa, a rare genetic eye disease that affects over one million people globally. Orphan Designation by the EMA provides Aldeyra with benefits such as reduced regulatory fees and up to 10 years of market exclusivity within the European Union, aiding in the continued development and potential future availability of ADX-2191. This follows a similar Orphan Drug Designation from the U.S. FDA, highlighting the international recognition of the treatment's potential.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated cont","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDL6wxVw4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2553220473","title":"Aldeyra Therapeutics Inc - Phase 2/3 Trial of Adx-2191 Expected in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553220473","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553220473?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:00","pubTimestamp":1753354800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nTUABDL5SB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"2553204674","title":"Aldeyra Therapeutics Receives Orphan Designation From the European Medicines Agency for Adx-2191 for the Treatment of Inherited Retinal Dystrophies Including Retinitis Pigmentosa","url":"https://stock-news.laohu8.com/highlight/detail?id=2553204674","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553204674?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:00","pubTimestamp":1753354800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nTUABDL5SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"2552748598","title":"Aldeyra Therapeutics Announces FDA Acceptance of Reproxalap NDA for Dry Eye Disease with PDUFA Target Date Set for December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2552748598","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552748598?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:00","pubTimestamp":1752750037,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Announces FDA Acceptance of Reproxalap NDA for Dry Eye Disease with PDUFA Target Date Set for December 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aldeyra Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL99dslz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2549475765","title":"Aldeyra Therapeutics Leads The Pack Among 3 Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2549475765","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549475765?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:04","pubTimestamp":1751972696,"startTime":"0","endTime":"0","summary":"The market has stayed flat over the past week, but it is up 13% over the past year, with earnings forecasted to grow by 15% annually. In such a setting, investors often look for stocks that combine value and growth potential, particularly those that may not be on everyone's radar. Penny stocks—though an outdated term—still offer intriguing opportunities when backed by strong financials and fundamentals, making them worth considering for investors seeking promising under-the-radar companies.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nmra/neumora-therapeutics/news/aldeyra-therapeutics-leads-the-pack-among-3-promising-penny","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4179","MAPS","BK4139","TTI","BABB","NMRA","BK4539","BK4142","ALDX","BK4173","TALK","BK4023","TLF","BK4121","BK4007","BK4141","CURI","BK4196","SQNS","BK4108","MRVI","TOUR","TTI.AU","WDH","BK4209","BK4509","BK7090","BK4094"],"gpt_icon":0},{"id":"2546717187","title":"Aldeyra Therapeutics: Positioned for Success with ADX-2191 and Strategic Portfolio Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2546717187","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546717187?lang=en_us&edition=fundamental","pubTime":"2025-06-27 18:37","pubTimestamp":1751020649,"startTime":"0","endTime":"0","summary":"BTIG analyst Thomas Shrader has maintained their bullish stance on ALDX stock, giving a Buy rating yesterday. Thomas Shrader has given his Buy rati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-positioned-for-success-with-adx-2191-and-strategic-portfolio-expansion-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-positioned-for-success-with-adx-2191-and-strategic-portfolio-expansion-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALDX","BK4139","ADX"],"gpt_icon":0},{"id":"2546573742","title":"Aldeyra Therapeutics (ALDX) Gets a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2546573742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546573742?lang=en_us&edition=fundamental","pubTime":"2025-06-26 23:35","pubTimestamp":1750952108,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Catherine Novack reiterated a Buy rating on Aldeyra Therapeutics (ALDX – Research Report) today and set a price target of $6.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aldeyra-therapeutics-aldx-gets-a-buy-from-jonestrading-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aldeyra-therapeutics-aldx-gets-a-buy-from-jonestrading-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"2546099784","title":"BRIEF-Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter From The U.S. Food And Drug Administration For Adx-2191","url":"https://stock-news.laohu8.com/highlight/detail?id=2546099784","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546099784?lang=en_us&edition=fundamental","pubTime":"2025-06-26 19:04","pubTimestamp":1750935883,"startTime":"0","endTime":"0","summary":"BRIEF-Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter From The U.S. Food And Drug Administration For Adx-2191June 26 (Reuters) - Aldeyra Therapeutics Inc ALDX.O:ALDEYRA THER","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nTUA6KVFWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2545538874","title":"Aldeyra Therapeutics: Buy Rating Affirmed Amidst Promising Developments in Dry Eye Disease Treatment and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2545538874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545538874?lang=en_us&edition=fundamental","pubTime":"2025-06-23 02:05","pubTimestamp":1750615512,"startTime":"0","endTime":"0","summary":"In a report released on June 18, Thomas Shrader from BTIG maintained a Buy rating on Aldeyra Therapeutics (ALDX – Research Report), with a price ta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-buy-rating-affirmed-amidst-promising-developments-in-dry-eye-disease-treatment-and-strategic-partnerships-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-buy-rating-affirmed-amidst-promising-developments-in-dry-eye-disease-treatment-and-strategic-partnerships-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALDX"],"gpt_icon":0},{"id":"2544969286","title":"Aldeyra Therapeutics Resubmits New Drug Application for Reproxalap to FDA for Dry Eye Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2544969286","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544969286?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:00","pubTimestamp":1750158045,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Inc., a biotechnology company focused on developing innovative therapies for immune-mediated and metabolic diseases, has announced the resubmission of a New Drug Application  to the U.S. Food and Drug Administration  for reproxalap, an investigational drug for dry eye disease. This resubmission follows the achievement of the primary endpoint in a Phase 3 clinical trial, addressing previous methodological concerns raised by the FDA in a Complete Response Letter received in April 2025. The trial showed statistically significant results favoring reproxalap, with no notable baseline differences across treatment arms and no safety concerns. The FDA is expected to acknowledge acceptance for review within 30 days and complete the review within 6 months as per the Prescription Drug User Fee Act guidelines.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL9Sy9Wy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2542322795","title":"Aldeyra Therapeutics Inc. Concluded Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542322795","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542322795?lang=en_us&edition=fundamental","pubTime":"2025-06-12 04:02","pubTimestamp":1749672134,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Inc. held its annual meeting of stockholders on June 10, 2025. During the meeting, stockholders elected three directors to serve as Class II directors. The appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, stockholders approved the compensation of the company's named executive officers on a non-binding, advisory basis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aldeyra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is sole","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL5bw3G1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2539426254","title":"Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2539426254","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539426254?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:01","pubTimestamp":1748516483,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Inc., a biotechnology company focused on developing therapies for immune-mediated and metabolic diseases, will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference. The event is scheduled for June 5, 2025, at 4:20 p.m. ET. Todd C. Brady, M.D., Ph.D., the company's President and CEO, will engage in a conversation with Clara Dong. The live webcast will be accessible via the Investors & Media section of Aldeyra's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aldeyra Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL8g1CXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2539404207","title":"CORRECTED-US FDA approves Alcon's new dry-eye drug (May 28)","url":"https://stock-news.laohu8.com/highlight/detail?id=2539404207","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539404207?lang=en_us&edition=fundamental","pubTime":"2025-05-29 05:42","pubTimestamp":1748468556,"startTime":"0","endTime":"0","summary":"CORRECTED-US FDA approves Alcon's new dry-eye drug  Corrects paragraph 3 in May 28 story to say \"eye drop\", not \"liquid medication\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nL3N3S01MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX","BK4198","BLCO"],"gpt_icon":0},{"id":"2537344987","title":"Aldeyra Therapeutics: Strong Financial Position and Positive Trial Outcomes Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2537344987","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537344987?lang=en_us&edition=fundamental","pubTime":"2025-05-21 19:16","pubTimestamp":1747826165,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics (ALDX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on May 19. Analyst Marc Goodma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-strong-financial-position-and-positive-trial-outcomes-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-strong-financial-position-and-positive-trial-outcomes-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALDX"],"gpt_icon":0},{"id":"2536683433","title":"Aldeyra Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536683433","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536683433?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:47","pubTimestamp":1747651620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 06:47 ET (10:47 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX"],"gpt_icon":0},{"id":"2536118688","title":"Aldeyra Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2536118688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536118688?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:16","pubTimestamp":1747649819,"startTime":"0","endTime":"0","summary":"Matthew Caufield, an analyst from H.C. Wainwright, reiterated the Buy rating on Aldeyra Therapeutics (ALDX – Research Report). The associated price...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-buy-rating-backed-by-promising-phase-3-results-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-buy-rating-backed-by-promising-phase-3-results-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALDX"],"gpt_icon":0},{"id":"2533562950","title":"BRIEF-Aldeyra Therapeutics Inc Says New Drug Application Resubmission Is Anticipated Mid‑2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533562950","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533562950?lang=en_us&edition=fundamental","pubTime":"2025-05-06 06:36","pubTimestamp":1746484614,"startTime":"0","endTime":"0","summary":"BRIEF-Aldeyra Therapeutics Inc Says New Drug Application Resubmission Is Anticipated Mid2025May 5 (Reuters) - Aldeyra Therapeutics Inc ALDX.O:ALDEYRA THERAPEUTICS INC - NEW DRUG APPLICATION RESUBMISSI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nFWN3RD1GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"2533356243","title":"Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2533356243","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533356243?lang=en_us&edition=fundamental","pubTime":"2025-05-06 06:34","pubTimestamp":1746484440,"startTime":"0","endTime":"0","summary":"In a Dry Eye Chamber Trial, Reproxalap Was Statistically Superior  to Vehicle in Primary Endpoint of Ocular Discomfort. Aldeyra Believes the Dry Eye Chamber Trial Results, including No Notable Differences in Baseline Scores Across Treatment Arms, Potentially Address FDA Feedback following the Prior NDA Review. A Recently Completed Dry Eye Disease Field Trial, which Was Numerically Supportive of Reproxalap and Consistent with Prior Field Trials, Did Not Reach Statistical Significance, and Is Expected to be Submitted to the Planned NDA Resubmission as Supportive. \"The dry eye chamber results announced today are representative of a number of clinical trials that highlight the potential rapid clinical effect of reproxalap on reducing ocular discomfort,\" stated Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra. \"With no notable baseline differences across treatment arms and highly statistically significant results in favor of reproxalap over vehicle, Aldeyra belie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aldeyra-therapeutics-achieves-primary-endpoint-223400713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2533563261","title":"Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap","url":"https://stock-news.laohu8.com/highlight/detail?id=2533563261","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533563261?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:00","pubTimestamp":1746475200,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., May 05, 2025----Aldeyra Therapeutics, Inc.   today announced it will host a webcast and conference call on Tuesday, May 6, 2025, at 8:00 a.m. ET to announce topline results from Phase 3 dry eye disease clinical trials of reproxalap. The dial-in numbers are  470-1428 for domestic callers and  975-4839 for international callers. The access code is 127477. A live audio webcast of the conference call will also be accessible from the \"Investors & Media\" section of Aldeyra's website at ir.aldeyra.com. After the live webcast, the event will remain archived on Aldeyra’s website for 90 days.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aldeyra-therapeutics-schedules-conference-call-200000907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ALDX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALDX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ALDX","fiscalQuarterEnding":"2025/03","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-02-28","symbol":"ALDX","fiscalQuarterEnding":"2024/12","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-11-07","symbol":"ALDX","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2024-08-01","symbol":"ALDX","fiscalQuarterEnding":"2024/06","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-05-02","symbol":"ALDX","fiscalQuarterEnding":"2024/03","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714622400000,"reportTimeType":"post","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1712203200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALDX","date":"2025-08-01","current":-5.179984,"percent":0.686434,"low":-21.345025,"twenty":-9.617736,"median":-6.567046,"eighty":-4.447844,"high":-1.518068,"avg":-7.325337,"sd":3.713465,"marketCap":298878984},"quantilePoints":[{"date":"2020-08-07","current":-5.591389,"twenty":-7.450247,"median":-5.745091,"eighty":-2.445136,"marketCap":275454245},{"date":"2020-08-14","current":-5.191444,"twenty":-7.450247,"median":-5.745091,"eighty":-2.465615,"marketCap":255751347},{"date":"2020-08-21","current":-5.756072,"twenty":-7.450247,"median":-5.745091,"eighty":-2.499772,"marketCap":283567203},{"date":"2020-08-28","current":-5.277706,"twenty":-7.450247,"median":-5.745091,"eighty":-2.547478,"marketCap":260000991},{"date":"2020-09-04","current":-4.587605,"twenty":-7.450247,"median":-5.745091,"eighty":-2.554643,"marketCap":226003833},{"date":"2020-09-11","current":-5.450232,"twenty":-7.450247,"median":-5.745091,"eighty":-2.567641,"marketCap":268500281},{"date":"2020-09-18","current":-5.82665,"twenty":-7.450247,"median":-5.745091,"eighty":-2.600704,"marketCap":287044185},{"date":"2020-09-25","current":-5.356127,"twenty":-7.450247,"median":-5.745091,"eighty":-2.649563,"marketCap":263864305},{"date":"2020-10-02","current":-5.465916,"twenty":-7.450247,"median":-5.753521,"eighty":-2.677093,"marketCap":269272943},{"date":"2020-10-09","current":-5.528652,"twenty":-7.450247,"median":-5.753521,"eighty":-2.69627,"marketCap":272363594},{"date":"2020-10-16","current":-6.352068,"twenty":-7.450247,"median":-5.754743,"eighty":-2.72917,"marketCap":312928385},{"date":"2020-10-23","current":-5.991334,"twenty":-7.450247,"median":-5.783311,"eighty":-2.762782,"marketCap":295157143},{"date":"2020-10-30","current":-5.238496,"twenty":-7.450247,"median":-5.783311,"eighty":-2.794108,"marketCap":258069335},{"date":"2020-11-06","current":-6.578022,"twenty":-7.450247,"median":-5.806866,"eighty":-2.816107,"marketCap":259319917},{"date":"2020-11-13","current":-6.617411,"twenty":-7.450247,"median":-5.8106,"eighty":-2.839803,"marketCap":260872731},{"date":"2020-11-20","current":-6.656801,"twenty":-7.450247,"median":-5.820575,"eighty":-2.855736,"marketCap":262425545},{"date":"2020-11-27","current":-6.834053,"twenty":-7.450247,"median":-5.845407,"eighty":-2.885464,"marketCap":269413208},{"date":"2020-12-04","current":-7.070389,"twenty":-7.450247,"median":-5.860399,"eighty":-2.891467,"marketCap":278730091},{"date":"2020-12-11","current":-6.863595,"twenty":-7.450247,"median":-5.870146,"eighty":-2.937247,"marketCap":270577818},{"date":"2020-12-18","current":-7.415046,"twenty":-7.450247,"median":-5.905071,"eighty":-2.967933,"marketCap":292317212},{"date":"2020-12-24","current":-7.159015,"twenty":-7.482285,"median":-5.930417,"eighty":-2.992865,"marketCap":282223922},{"date":"2020-12-31","current":-6.755274,"twenty":-7.482285,"median":-5.9325,"eighty":-3.013003,"marketCap":266307580},{"date":"2021-01-08","current":-10.152606,"twenty":-7.490821,"median":-5.962176,"eighty":-3.073374,"marketCap":400237777},{"date":"2021-01-15","current":-15.486387,"twenty":-7.503288,"median":-5.991987,"eighty":-3.09508,"marketCap":610506996},{"date":"2021-01-22","current":-14.555387,"twenty":-7.556909,"median":-6.007552,"eighty":-3.124689,"marketCap":573804958},{"date":"2021-01-29","current":-13.26447,"twenty":-7.591549,"median":-6.053967,"eighty":-3.144412,"marketCap":522914201},{"date":"2021-02-05","current":-14.910685,"twenty":-7.624996,"median":-6.078755,"eighty":-3.15008,"marketCap":587811589},{"date":"2021-02-12","current":-15.040961,"twenty":-7.693335,"median":-6.132709,"eighty":-3.183005,"marketCap":592947353},{"date":"2021-02-19","current":-15.100177,"twenty":-7.767064,"median":-6.142149,"eighty":-3.201241,"marketCap":595281792},{"date":"2021-02-26","current":-14.519857,"twenty":-7.796919,"median":-6.16163,"eighty":-3.220941,"marketCap":572404295},{"date":"2021-03-05","current":-13.240783,"twenty":-7.828557,"median":-6.177517,"eighty":-3.243557,"marketCap":521980426},{"date":"2021-03-12","current":-15.751579,"twenty":-7.873355,"median":-6.190523,"eighty":-3.266425,"marketCap":591530524},{"date":"2021-03-19","current":-15.072198,"twenty":-7.896823,"median":-6.205642,"eighty":-3.310684,"marketCap":566017227},{"date":"2021-03-26","current":-14.040545,"twenty":-7.935871,"median":-6.232712,"eighty":-3.406836,"marketCap":527274812},{"date":"2021-04-01","current":-15.462213,"twenty":-7.956092,"median":-6.233579,"eighty":-3.452595,"marketCap":580663749},{"date":"2021-04-09","current":-15.147684,"twenty":-7.959625,"median":-6.233579,"eighty":-3.440211,"marketCap":568852037},{"date":"2021-04-16","current":-14.280718,"twenty":-7.959625,"median":-6.233579,"eighty":-3.440211,"marketCap":536294199},{"date":"2021-04-23","current":-13.419823,"twenty":-7.959625,"median":-6.233579,"eighty":-3.440211,"marketCap":503964407},{"date":"2021-04-30","current":-19.261089,"twenty":-7.959625,"median":-6.233579,"eighty":-3.440211,"marketCap":723325716},{"date":"2021-05-07","current":-18.45361,"twenty":-7.959625,"median":-6.233579,"eighty":-3.440211,"marketCap":719237413},{"date":"2021-05-14","current":-17.950868,"twenty":-8.047151,"median":-6.233579,"eighty":-3.440211,"marketCap":699642804},{"date":"2021-05-21","current":-17.344619,"twenty":-8.094651,"median":-6.233579,"eighty":-3.440211,"marketCap":676014011},{"date":"2021-05-28","current":-18.512756,"twenty":-8.112232,"median":-6.233579,"eighty":-3.440211,"marketCap":721542661},{"date":"2021-06-04","current":-18.690195,"twenty":-8.112232,"median":-6.233579,"eighty":-3.440211,"marketCap":728458405},{"date":"2021-06-11","current":-18.246599,"twenty":-8.112232,"median":-6.233579,"eighty":-3.440211,"marketCap":711169045},{"date":"2021-06-18","current":-17.625564,"twenty":-8.112232,"median":-6.233579,"eighty":-3.440211,"marketCap":686963939},{"date":"2021-06-25","current":-16.960169,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":661029898},{"date":"2021-07-02","current":-16.146909,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":629332736},{"date":"2021-07-09","current":-15.939897,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":621264368},{"date":"2021-07-16","current":-14.076792,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":548649052},{"date":"2021-07-23","current":-13.411398,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":522715011},{"date":"2021-07-30","current":-13.160027,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":512917706},{"date":"2021-08-06","current":-12.248303,"twenty":-8.131581,"median":-6.233579,"eighty":-3.440211,"marketCap":568224823},{"date":"2021-08-13","current":-11.587244,"twenty":-8.140064,"median":-6.233579,"eighty":-3.440211,"marketCap":537556885},{"date":"2021-08-20","current":-10.352436,"twenty":-8.213456,"median":-6.233579,"eighty":-3.440211,"marketCap":480271490},{"date":"2021-08-27","current":-11.275424,"twenty":-8.254758,"median":-6.233579,"eighty":-3.440211,"marketCap":523090876},{"date":"2021-09-03","current":-11.499935,"twenty":-8.345275,"median":-6.233579,"eighty":-3.440211,"marketCap":533506402},{"date":"2021-09-10","current":-10.976076,"twenty":-8.427687,"median":-6.233579,"eighty":-3.440211,"marketCap":509203508},{"date":"2021-09-17","current":-10.689202,"twenty":-8.455414,"median":-6.233579,"eighty":-3.440211,"marketCap":495894779},{"date":"2021-09-24","current":-10.601892,"twenty":-8.455414,"median":-6.233579,"eighty":-3.440211,"marketCap":491844297},{"date":"2021-10-01","current":-11.063386,"twenty":-8.455414,"median":-6.233579,"eighty":-3.440211,"marketCap":513253990},{"date":"2021-10-08","current":-10.527055,"twenty":-8.455414,"median":-6.233579,"eighty":-3.440211,"marketCap":488372455},{"date":"2021-10-15","current":-10.402327,"twenty":-8.455414,"median":-6.233579,"eighty":-3.440211,"marketCap":482586051},{"date":"2021-10-22","current":-10.01567,"twenty":-8.455414,"median":-6.233579,"eighty":-3.440211,"marketCap":464648201},{"date":"2021-10-29","current":-9.915577,"twenty":-8.562247,"median":-6.233579,"eighty":-3.440211,"marketCap":528638155},{"date":"2021-11-05","current":-9.741237,"twenty":-8.719765,"median":-6.233579,"eighty":-3.440211,"marketCap":519343418},{"date":"2021-11-12","current":-9.610482,"twenty":-8.980277,"median":-6.233579,"eighty":-3.440211,"marketCap":512372366},{"date":"2021-11-19","current":-8.640717,"twenty":-9.110949,"median":-6.233579,"eighty":-3.440211,"marketCap":460670392},{"date":"2021-11-26","current":-8.368311,"twenty":-9.110949,"median":-6.233579,"eighty":-3.440211,"marketCap":446147366},{"date":"2021-12-03","current":-7.507508,"twenty":-9.110949,"median":-6.233579,"eighty":-3.440211,"marketCap":400254603},{"date":"2021-12-10","current":-7.551093,"twenty":-9.110949,"median":-6.241878,"eighty":-3.440211,"marketCap":402578287},{"date":"2021-12-17","current":-7.670952,"twenty":-9.110949,"median":-6.266923,"eighty":-3.440211,"marketCap":408968419},{"date":"2021-12-23","current":-4.543731,"twenty":-9.110949,"median":-6.280316,"eighty":-3.440211,"marketCap":242244077},{"date":"2021-12-31","current":-4.358495,"twenty":-9.110949,"median":-6.266923,"eighty":-3.440211,"marketCap":232368420},{"date":"2022-01-07","current":-4.195052,"twenty":-9.093068,"median":-6.249319,"eighty":-3.452595,"marketCap":223654604},{"date":"2022-01-14","current":-4.118778,"twenty":-9.093068,"median":-6.223021,"eighty":-3.452595,"marketCap":219588156},{"date":"2022-01-21","current":-3.541278,"twenty":-9.093068,"median":-6.205642,"eighty":-3.452595,"marketCap":188799341},{"date":"2022-01-28","current":-3.73741,"twenty":-9.093068,"median":-6.185758,"eighty":-3.452595,"marketCap":199255920},{"date":"2022-02-04","current":-3.857268,"twenty":-9.093068,"median":-6.170324,"eighty":-3.452595,"marketCap":205646051},{"date":"2022-02-11","current":-4.195052,"twenty":-9.075186,"median":-6.166862,"eighty":-3.46498,"marketCap":223654604},{"date":"2022-02-18","current":-4.195052,"twenty":-9.075186,"median":-6.16163,"eighty":-3.46498,"marketCap":223654604},{"date":"2022-02-25","current":-4.445665,"twenty":-9.075186,"median":-6.141595,"eighty":-3.46498,"marketCap":237015788},{"date":"2022-03-04","current":-3.813683,"twenty":-9.075186,"median":-6.117618,"eighty":-3.46498,"marketCap":203322367},{"date":"2022-03-11","current":-4.467458,"twenty":-9.075186,"median":-6.062118,"eighty":-3.46498,"marketCap":238177630},{"date":"2022-03-18","current":-4.977647,"twenty":-9.075186,"median":-6.025624,"eighty":-3.46498,"marketCap":287589876},{"date":"2022-03-25","current":-4.877088,"twenty":-9.075186,"median":-5.991661,"eighty":-3.46498,"marketCap":281779980},{"date":"2022-04-01","current":-4.736306,"twenty":-9.075186,"median":-5.957149,"eighty":-3.46498,"marketCap":273646125},{"date":"2022-04-08","current":-4.756418,"twenty":-9.075186,"median":-5.926721,"eighty":-3.46498,"marketCap":274808104},{"date":"2022-04-14","current":-4.585468,"twenty":-9.075186,"median":-5.888378,"eighty":-3.46498,"marketCap":264931280},{"date":"2022-04-22","current":-3.559772,"twenty":-9.075186,"median":-5.867027,"eighty":-3.46498,"marketCap":205670336},{"date":"2022-04-29","current":-3.097908,"twenty":-9.075186,"median":-5.867027,"eighty":-3.402943,"marketCap":178985577},{"date":"2022-05-06","current":-2.497002,"twenty":-9.075186,"median":-5.867027,"eighty":-3.321629,"marketCap":157997040},{"date":"2022-05-13","current":-2.294293,"twenty":-9.075186,"median":-5.867027,"eighty":-3.266425,"marketCap":145170712},{"date":"2022-05-20","current":-2.625998,"twenty":-9.075186,"median":-5.867027,"eighty":-3.244531,"marketCap":166159249},{"date":"2022-05-27","current":-2.856349,"twenty":-9.075186,"median":-5.867027,"eighty":-3.224387,"marketCap":180734622},{"date":"2022-06-03","current":-2.810279,"twenty":-9.075186,"median":-5.867027,"eighty":-3.211282,"marketCap":177819547},{"date":"2022-06-10","current":-3.289408,"twenty":-9.075186,"median":-5.867027,"eighty":-3.206383,"marketCap":208136322},{"date":"2022-06-17","current":-3.086699,"twenty":-9.075186,"median":-5.867027,"eighty":-3.18876,"marketCap":195309994},{"date":"2022-06-24","current":-3.390762,"twenty":-9.093068,"median":-5.867443,"eighty":-3.168117,"marketCap":214549486},{"date":"2022-07-01","current":-3.501331,"twenty":-9.093068,"median":-5.867443,"eighty":-3.168117,"marketCap":221545665},{"date":"2022-07-08","current":-4.137099,"twenty":-9.093068,"median":-5.867443,"eighty":-3.168117,"marketCap":261773694},{"date":"2022-07-15","current":-4.349021,"twenty":-9.093068,"median":-5.867443,"eighty":-3.168117,"marketCap":275183037},{"date":"2022-07-22","current":-4.809723,"twenty":-9.093068,"median":-5.867443,"eighty":-3.168117,"marketCap":304333783},{"date":"2022-07-29","current":-4.64387,"twenty":-9.093068,"median":-5.867443,"eighty":-3.168117,"marketCap":293839514},{"date":"2022-08-05","current":-6.104108,"twenty":-9.093068,"median":-5.870146,"eighty":-3.168117,"marketCap":403595962},{"date":"2022-08-12","current":-6.589261,"twenty":-9.093068,"median":-5.921076,"eighty":-3.168117,"marketCap":435673676},{"date":"2022-08-19","current":-6.12175,"twenty":-9.093068,"median":-5.952123,"eighty":-3.168117,"marketCap":404762425},{"date":"2022-08-26","current":-6.342274,"twenty":-9.093068,"median":-5.991334,"eighty":-3.168117,"marketCap":419343204},{"date":"2022-09-02","current":-6.12175,"twenty":-9.093068,"median":-6.029449,"eighty":-3.168117,"marketCap":404762425},{"date":"2022-09-09","current":-5.795374,"twenty":-9.093068,"median":-6.029449,"eighty":-3.168117,"marketCap":383182872},{"date":"2022-09-16","current":-5.548387,"twenty":-9.025282,"median":-5.99944,"eighty":-3.168117,"marketCap":366852399},{"date":"2022-09-23","current":-4.798605,"twenty":-8.995212,"median":-5.973134,"eighty":-3.168117,"marketCap":317277751},{"date":"2022-09-30","current":-4.710396,"twenty":-8.995212,"median":-5.939818,"eighty":-3.168117,"marketCap":311445439},{"date":"2022-10-07","current":-4.710396,"twenty":-8.995212,"median":-5.902555,"eighty":-3.168117,"marketCap":311445439},{"date":"2022-10-14","current":-4.586902,"twenty":-8.995212,"median":-5.866612,"eighty":-3.168117,"marketCap":303280203},{"date":"2022-10-21","current":-4.639828,"twenty":-8.995212,"median":-5.852475,"eighty":-3.168117,"marketCap":306779590},{"date":"2022-10-28","current":-4.939741,"twenty":-8.995212,"median":-5.828027,"eighty":-3.168117,"marketCap":326609449},{"date":"2022-11-04","current":-4.710396,"twenty":-8.995212,"median":-5.81681,"eighty":-3.168117,"marketCap":311445439},{"date":"2022-11-11","current":-5.244292,"twenty":-8.995212,"median":-5.79593,"eighty":-3.168117,"marketCap":340234053},{"date":"2022-11-18","current":-4.68466,"twenty":-8.995212,"median":-5.756072,"eighty":-3.168117,"marketCap":303926804},{"date":"2022-11-25","current":-4.928371,"twenty":-8.995212,"median":-5.745438,"eighty":-3.168117,"marketCap":319738025},{"date":"2022-12-02","current":-5.885161,"twenty":-8.995212,"median":-5.725248,"eighty":-3.168117,"marketCap":381811708},{"date":"2022-12-09","current":-5.542161,"twenty":-8.995212,"median":-5.698344,"eighty":-3.168117,"marketCap":359558878},{"date":"2022-12-16","current":-5.704634,"twenty":-8.995212,"median":-5.678973,"eighty":-3.168117,"marketCap":370099692},{"date":"2022-12-23","current":-5.957371,"twenty":-8.995212,"median":-5.670218,"eighty":-3.168117,"marketCap":386496514},{"date":"2022-12-30","current":-6.282319,"twenty":-8.995212,"median":-5.670218,"eighty":-3.168117,"marketCap":407578142},{"date":"2023-01-06","current":-6.300372,"twenty":-8.995212,"median":-5.670218,"eighty":-3.168117,"marketCap":408749344},{"date":"2023-01-13","current":-5.821977,"twenty":-8.995212,"median":-5.670218,"eighty":-3.168117,"marketCap":377712503},{"date":"2023-01-20","current":-5.704634,"twenty":-8.995212,"median":-5.654125,"eighty":-3.168117,"marketCap":370099692},{"date":"2023-01-27","current":-5.497029,"twenty":-8.995212,"median":-5.64145,"eighty":-3.168117,"marketCap":356630875},{"date":"2023-02-03","current":-5.578266,"twenty":-8.995212,"median":-5.627776,"eighty":-3.168117,"marketCap":361901282},{"date":"2023-02-10","current":-5.704634,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":370099692},{"date":"2023-02-17","current":-6.417714,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":416362154},{"date":"2023-02-24","current":-6.462845,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":419290158},{"date":"2023-03-03","current":-6.751688,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":438029383},{"date":"2023-03-10","current":-6.780825,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":420578193},{"date":"2023-03-17","current":-7.130255,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":442251442},{"date":"2023-03-24","current":-8.527973,"twenty":-8.995212,"median":-5.622757,"eighty":-3.168117,"marketCap":528944440},{"date":"2023-03-31","current":-9.377937,"twenty":-9.03249,"median":-5.625267,"eighty":-3.171112,"marketCap":581663155},{"date":"2023-04-06","current":-9.189057,"twenty":-9.300198,"median":-5.625267,"eighty":-3.171112,"marketCap":569947885},{"date":"2023-04-14","current":-9.746255,"twenty":-9.376048,"median":-5.614915,"eighty":-3.162128,"marketCap":604507932},{"date":"2023-04-21","current":-9.632927,"twenty":-9.490154,"median":-5.614915,"eighty":-3.162128,"marketCap":597478770},{"date":"2023-04-28","current":-8.546861,"twenty":-9.503657,"median":-5.614915,"eighty":-3.159134,"marketCap":530115967},{"date":"2023-05-05","current":-10.001447,"twenty":-9.575046,"median":-5.614915,"eighty":-3.159134,"marketCap":608608276},{"date":"2023-05-12","current":-9.999554,"twenty":-9.632927,"median":-5.614915,"eighty":-3.159134,"marketCap":608493091},{"date":"2023-05-19","current":-9.289121,"twenty":-9.741237,"median":-5.614915,"eighty":-3.159134,"marketCap":565261777},{"date":"2023-05-26","current":-8.855949,"twenty":-9.741237,"median":-5.614915,"eighty":-3.159134,"marketCap":538902420},{"date":"2023-06-01","current":-9.135104,"twenty":-9.741237,"median":-5.614915,"eighty":-3.159134,"marketCap":555889561},{"date":"2023-06-09","current":-11.445352,"twenty":-9.781881,"median":-5.614915,"eighty":-3.157705,"marketCap":696472801},{"date":"2023-06-16","current":-10.463496,"twenty":-9.813088,"median":-5.614915,"eighty":-3.157705,"marketCap":636724924},{"date":"2023-06-23","current":-7.460175,"twenty":-9.820861,"median":-5.614643,"eighty":-3.156277,"marketCap":453966712},{"date":"2023-06-30","current":-7.604565,"twenty":-9.8233,"median":-5.614371,"eighty":-3.154848,"marketCap":462753165},{"date":"2023-07-05","current":-7.681573,"twenty":-9.8233,"median":-5.614371,"eighty":-3.154848,"marketCap":467439273},{"date":"2023-07-12","current":-7.566061,"twenty":-9.828178,"median":-5.614371,"eighty":-3.151991,"marketCap":460410111},{"date":"2023-07-21","current":-7.691199,"twenty":-9.853303,"median":-5.607073,"eighty":-3.151991,"marketCap":468025036},{"date":"2023-07-28","current":-7.354288,"twenty":-9.859787,"median":-5.602694,"eighty":-3.151991,"marketCap":447523314},{"date":"2023-08-04","current":-8.914643,"twenty":-9.859787,"median":-5.607073,"eighty":-3.151991,"marketCap":464079132},{"date":"2023-08-11","current":-8.576968,"twenty":-9.859787,"median":-5.614371,"eighty":-3.151991,"marketCap":446500377},{"date":"2023-08-18","current":-8.160501,"twenty":-9.859787,"median":-5.627776,"eighty":-3.151991,"marketCap":424819912},{"date":"2023-08-25","current":-8.278687,"twenty":-9.859787,"median":-5.64145,"eighty":-3.151991,"marketCap":430972476},{"date":"2023-09-01","current":-8.396874,"twenty":-9.859787,"median":-5.654125,"eighty":-3.151991,"marketCap":437125041},{"date":"2023-09-08","current":-8.126733,"twenty":-9.859787,"median":-5.669809,"eighty":-3.151991,"marketCap":423062037},{"date":"2023-09-15","current":-7.834081,"twenty":-9.859787,"median":-5.67577,"eighty":-3.151991,"marketCap":407827116},{"date":"2023-09-22","current":-6.967379,"twenty":-9.859787,"median":-5.680702,"eighty":-3.151991,"marketCap":362708311},{"date":"2023-09-29","current":-7.04617,"twenty":-9.818422,"median":-5.680702,"eighty":-3.151991,"marketCap":366810021},{"date":"2023-10-06","current":-6.550912,"twenty":-9.79123,"median":-5.680702,"eighty":-3.151991,"marketCap":341027847},{"date":"2023-10-13","current":-6.06691,"twenty":-9.757165,"median":-5.680702,"eighty":-3.151991,"marketCap":315831631},{"date":"2023-10-20","current":-1.868473,"twenty":-9.63787,"median":-5.670013,"eighty":-3.147213,"marketCap":97269111},{"date":"2023-10-27","current":-1.76717,"twenty":-9.610534,"median":-5.656112,"eighty":-3.146519,"marketCap":91995484},{"date":"2023-11-03","current":-2.352475,"twenty":-9.552867,"median":-5.640939,"eighty":-3.141046,"marketCap":122465326},{"date":"2023-11-10","current":-3.031754,"twenty":-9.474158,"median":-5.618836,"eighty":-3.121982,"marketCap":138526005},{"date":"2023-11-17","current":-3.205548,"twenty":-9.474158,"median":-5.609485,"eighty":-3.113197,"marketCap":146466986},{"date":"2023-11-24","current":-3.257043,"twenty":-9.474158,"median":-5.596319,"eighty":-3.113197,"marketCap":148819869},{"date":"2023-11-30","current":-3.566012,"twenty":-9.4779,"median":-5.583547,"eighty":-3.112073,"marketCap":162937169},{"date":"2023-12-08","current":-4.171075,"twenty":-9.4779,"median":-5.571605,"eighty":-3.112073,"marketCap":190583548},{"date":"2023-12-15","current":-3.836359,"twenty":-9.4779,"median":-5.542161,"eighty":-3.112073,"marketCap":175289807},{"date":"2023-12-22","current":-4.312686,"twenty":-9.4779,"median":-5.506055,"eighty":-3.112073,"marketCap":197053978},{"date":"2023-12-29","current":-4.647401,"twenty":-9.481641,"median":-5.501078,"eighty":-3.110949,"marketCap":212347719},{"date":"2024-01-05","current":-4.299812,"twenty":-9.481641,"median":-5.488003,"eighty":-3.109785,"marketCap":196465757},{"date":"2024-01-12","current":-4.11958,"twenty":-9.481641,"median":-5.478976,"eighty":-3.109785,"marketCap":188230665},{"date":"2024-01-19","current":-3.913601,"twenty":-9.481641,"median":-5.467949,"eighty":-3.108621,"marketCap":178819132},{"date":"2024-01-26","current":-3.913601,"twenty":-9.481641,"median":-5.450232,"eighty":-3.109785,"marketCap":178819132},{"date":"2024-02-02","current":-4.106707,"twenty":-9.481641,"median":-5.407252,"eighty":-3.109785,"marketCap":187642444},{"date":"2024-02-09","current":-4.158201,"twenty":-9.481641,"median":-5.379653,"eighty":-3.109785,"marketCap":189995328},{"date":"2024-02-16","current":-4.634528,"twenty":-9.481641,"median":-5.324759,"eighty":-3.109785,"marketCap":211759498},{"date":"2024-02-23","current":-4.557286,"twenty":-9.481641,"median":-5.303943,"eighty":-3.109785,"marketCap":208230173},{"date":"2024-03-01","current":-4.660275,"twenty":-9.481641,"median":-5.258729,"eighty":-3.110949,"marketCap":212935940},{"date":"2024-03-08","current":-6.070569,"twenty":-9.481641,"median":-5.239043,"eighty":-3.110949,"marketCap":227904411},{"date":"2024-03-15","current":-4.345508,"twenty":-9.481641,"median":-5.197793,"eighty":-3.110949,"marketCap":163141277},{"date":"2024-03-22","current":-4.565137,"twenty":-9.481641,"median":-5.119395,"eighty":-3.110949,"marketCap":171386684},{"date":"2024-03-28","current":-4.831828,"twenty":-9.481641,"median":-5.094682,"eighty":-3.110949,"marketCap":181398965},{"date":"2024-04-05","current":-7.349713,"twenty":-9.481641,"median":-5.090845,"eighty":-3.109785,"marketCap":275926673},{"date":"2024-04-12","current":-6.902612,"twenty":-9.481641,"median":-5.090845,"eighty":-3.109785,"marketCap":259141379},{"date":"2024-04-19","current":-6.243726,"twenty":-9.481641,"median":-5.090845,"eighty":-3.109785,"marketCap":234405156},{"date":"2024-04-26","current":-6.235414,"twenty":-9.481641,"median":-5.094682,"eighty":-3.110949,"marketCap":234093086},{"date":"2024-05-03","current":-8.335346,"twenty":-9.481641,"median":-5.094682,"eighty":-3.110949,"marketCap":250134998},{"date":"2024-05-10","current":-7.800775,"twenty":-9.481641,"median":-5.10734,"eighty":-3.110949,"marketCap":234093086},{"date":"2024-05-17","current":-8.097759,"twenty":-9.481641,"median":-5.129896,"eighty":-3.110949,"marketCap":243005260},{"date":"2024-05-24","current":-7.503791,"twenty":-9.481641,"median":-5.203531,"eighty":-3.110949,"marketCap":225180913},{"date":"2024-05-31","current":-7.642383,"twenty":-9.481641,"median":-5.241941,"eighty":-3.110949,"marketCap":229339927},{"date":"2024-06-07","current":-7.642383,"twenty":-9.481641,"median":-5.305153,"eighty":-3.110949,"marketCap":229339927},{"date":"2024-06-14","current":-7.384998,"twenty":-9.481641,"median":-5.329065,"eighty":-3.110949,"marketCap":221616043},{"date":"2024-06-21","current":-6.890024,"twenty":-9.481641,"median":-5.379653,"eighty":-3.109785,"marketCap":206762421},{"date":"2024-06-28","current":-6.553443,"twenty":-9.481641,"median":-5.411021,"eighty":-3.109785,"marketCap":196661958},{"date":"2024-07-05","current":-6.315856,"twenty":-9.481641,"median":-5.451898,"eighty":-3.109785,"marketCap":189532219},{"date":"2024-07-12","current":-7.642383,"twenty":-9.481641,"median":-5.473758,"eighty":-3.109785,"marketCap":229339927},{"date":"2024-07-19","current":-7.563188,"twenty":-9.481641,"median":-5.488003,"eighty":-3.109785,"marketCap":226963347},{"date":"2024-07-26","current":-8.216552,"twenty":-9.481641,"median":-5.497029,"eighty":-3.109785,"marketCap":246570129},{"date":"2024-08-02","current":-5.515431,"twenty":-9.481641,"median":-5.515082,"eighty":-3.109785,"marketCap":208866751},{"date":"2024-08-09","current":-8.002474,"twenty":-9.481641,"median":-5.528652,"eighty":-3.127395,"marketCap":303049910},{"date":"2024-08-16","current":-7.955401,"twenty":-9.481641,"median":-5.567862,"eighty":-3.145451,"marketCap":301267263},{"date":"2024-08-23","current":-8.739957,"twenty":-9.481641,"median":-5.583547,"eighty":-3.16394,"marketCap":330978039},{"date":"2024-08-30","current":-9.030243,"twenty":-9.481641,"median":-5.596319,"eighty":-3.200147,"marketCap":341971026},{"date":"2024-09-06","current":-9.61866,"twenty":-9.601765,"median":-5.614371,"eighty":-3.211282,"marketCap":364254107},{"date":"2024-09-13","current":-9.461749,"twenty":-9.614963,"median":-5.638441,"eighty":-3.236619,"marketCap":358311952},{"date":"2024-09-20","current":-9.242073,"twenty":-9.614963,"median":-5.669809,"eighty":-3.255733,"marketCap":349992935},{"date":"2024-09-27","current":-8.630119,"twenty":-9.614963,"median":-5.701177,"eighty":-3.315207,"marketCap":326818530},{"date":"2024-10-04","current":-8.379061,"twenty":-9.614963,"median":-5.733627,"eighty":-3.370379,"marketCap":317311082},{"date":"2024-10-11","current":-8.426135,"twenty":-9.614963,"median":-5.795374,"eighty":-3.465597,"marketCap":319093728},{"date":"2024-10-18","current":-8.943942,"twenty":-9.614963,"median":-5.821408,"eighty":-3.555727,"marketCap":338702840},{"date":"2024-10-25","current":-8.355524,"twenty":-9.614963,"median":-5.849056,"eighty":-3.579019,"marketCap":316419759},{"date":"2024-11-01","current":-8.410443,"twenty":-9.614963,"median":-5.944281,"eighty":-3.662938,"marketCap":318499513},{"date":"2024-11-08","current":-7.338075,"twenty":-9.614963,"median":-5.991334,"eighty":-3.682919,"marketCap":328713780},{"date":"2024-11-15","current":-5.596612,"twenty":-9.614963,"median":-6.055473,"eighty":-3.740104,"marketCap":250703807},{"date":"2024-11-22","current":-6.447403,"twenty":-9.614963,"median":-6.101793,"eighty":-3.806317,"marketCap":288815550},{"date":"2024-11-29","current":-6.513871,"twenty":-9.614963,"median":-6.111934,"eighty":-3.821794,"marketCap":291793030},{"date":"2024-12-06","current":-6.939267,"twenty":-9.614963,"median":-6.187936,"eighty":-3.853086,"marketCap":310848901},{"date":"2024-12-13","current":-6.513871,"twenty":-9.614963,"median":-6.228039,"eighty":-3.913601,"marketCap":291793030},{"date":"2024-12-20","current":-6.487284,"twenty":-9.614963,"median":-6.236423,"eighty":-3.960049,"marketCap":290602038},{"date":"2024-12-27","current":-6.567046,"twenty":-9.614963,"median":-6.264266,"eighty":-3.986012,"marketCap":294175014},{"date":"2025-01-03","current":-7.24502,"twenty":-9.614963,"median":-6.301174,"eighty":-4.005322,"marketCap":324545309},{"date":"2025-01-10","current":-6.567046,"twenty":-9.615887,"median":-6.315834,"eighty":-4.016591,"marketCap":294175014},{"date":"2025-01-17","current":-6.43411,"twenty":-9.615887,"median":-6.331708,"eighty":-4.054488,"marketCap":288220054},{"date":"2025-01-24","current":-6.806331,"twenty":-9.615887,"median":-6.348299,"eighty":-4.07258,"marketCap":304893941},{"date":"2025-01-31","current":-6.965854,"twenty":-9.615887,"median":-6.3726,"eighty":-4.091523,"marketCap":312039893},{"date":"2025-02-07","current":-7.883114,"twenty":-9.615887,"median":-6.403592,"eighty":-4.118735,"marketCap":353129116},{"date":"2025-02-14","current":-8.627556,"twenty":-9.615887,"median":-6.428526,"eighty":-4.135241,"marketCap":386476891},{"date":"2025-02-21","current":-8.893428,"twenty":-9.615887,"median":-6.434649,"eighty":-4.158201,"marketCap":398386810},{"date":"2025-02-28","current":-5.462907,"twenty":-9.615887,"median":-6.475065,"eighty":-4.184156,"marketCap":305111221},{"date":"2025-03-07","current":-6.788543,"twenty":-9.616812,"median":-6.501051,"eighty":-4.209696,"marketCap":379149952},{"date":"2025-03-14","current":-7.387218,"twenty":-9.616812,"median":-6.513845,"eighty":-4.248803,"marketCap":412586799},{"date":"2025-03-21","current":-7.034428,"twenty":-9.616812,"median":-6.553443,"eighty":-4.299812,"marketCap":392882943},{"date":"2025-03-28","current":-7.130643,"twenty":-9.616812,"median":-6.567046,"eighty":-4.312686,"marketCap":398256722},{"date":"2025-04-04","current":-2.020527,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":112849356},{"date":"2025-04-11","current":-2.041908,"twenty":-9.615887,"median":-6.567046,"eighty":-4.32041,"marketCap":114043529},{"date":"2025-04-17","current":-2.341246,"twenty":-9.615887,"median":-6.567046,"eighty":-4.32041,"marketCap":130761952},{"date":"2025-04-25","current":-2.852608,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":159322264},{"date":"2025-05-02","current":-3.013469,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":168306602},{"date":"2025-05-09","current":-2.337851,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":130572381},{"date":"2025-05-16","current":-2.242238,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":129374470},{"date":"2025-05-23","current":-2.335664,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":134765073},{"date":"2025-05-30","current":-2.366806,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":136561940},{"date":"2025-06-06","current":-2.543279,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":146744190},{"date":"2025-06-13","current":-3.041554,"twenty":-9.616812,"median":-6.567046,"eighty":-4.330017,"marketCap":175494072},{"date":"2025-06-20","current":-3.290691,"twenty":-9.617736,"median":-6.567046,"eighty":-4.337049,"marketCap":189869013},{"date":"2025-06-27","current":-4.017342,"twenty":-9.617736,"median":-6.567046,"eighty":-4.337049,"marketCap":231795925},{"date":"2025-07-03","current":-4.463714,"twenty":-9.617736,"median":-6.567046,"eighty":-4.339848,"marketCap":257551028},{"date":"2025-07-11","current":-4.98275,"twenty":-9.617736,"median":-6.567046,"eighty":-4.359035,"marketCap":287498822},{"date":"2025-07-18","current":-5.221507,"twenty":-9.617736,"median":-6.567046,"eighty":-4.382059,"marketCap":301274807},{"date":"2025-07-25","current":-5.647117,"twenty":-9.617736,"median":-6.567046,"eighty":-4.424808,"marketCap":325831998},{"date":"2025-08-01","current":-5.179984,"twenty":-9.617736,"median":-6.567046,"eighty":-4.447844,"marketCap":298878984}],"updateTime":1754136291198}}}